Daniel focuses his practice on patent work, especially patent litigation. As a trial team member, he deposes witnesses, drafts motions, coordinates discovery and assists with developing case strategies. He represents national and global corporations involving a wide range of technologies such as software and telecommunications, systems for monitoring power grids, and life sciences and biotechnology.
Daniel is especially knowledgeable on patents related to molecular biology. Before attending law school, he received a master’s degree in molecular biology from Loyola University-Chicago, focusing his research on receptor mediated effects on important signal transduction pathways and cell migration upon receptor activation with various molecules.
Co-Author, CXC Chemokine Receptor 4 Signaling Upon Co-Activation With Stromal Cell-Derived Factor-1α and Ubiquitin, 65 Cytokine 121 (2013).
Co-Author, The CXC Chemokine Receptor 4 Ligands Ubiquitin and Stromal Cell-Derived Factor-1α Function Through Distinct Receptor Interactions, 286 J. Biological Chemistry 33466 (2011).